| JYSB1400195 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2014-09-17 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2016-02-22 | view |
| JYSZ2100514 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | License Renew | 2021-05-10 | | | | | view |
| JYSB1900120 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-06-10 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-07-09 | view |
| JXSS1700003 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2017-03-28 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2018-05-08 | view |
| JXSL0600043 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(7) | Import Drug Application | 2006-11-23 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2008-06-20 | view |
| JYSB2300087 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2023-05-09 | | | | | view |
| JXSL2000058 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-05-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-05-23 | view |
| JYSB1700154 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2017-09-06 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2018-11-16 | view |
| JXSS1400002 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2014-03-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2018-11-16 | view |
| JXSS2000046 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JYSB1900039 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-01-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-16 | view |
| JYSB1500154 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2015-06-08 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2015-10-30 | view |
| CXSS2300004 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-29 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2000087 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2020-04-03 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-04-07 | view |
| CXSL1700010 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(2) | New Drug Application | 2017-07-03 | 上海联合赛尔生物工程有限公司 | Shanghai United Cell Biotechnology Co Ltd | In Review | 2017-06-30 | view |
| JXSL1000041 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2010-09-09 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2011-08-02 | view |
| JXSL2000131 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2020-07-17 | 上海艾迈医疗科技有限公司 | 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited | In Review | 2020-07-16 | view |
| JXSL2101039 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(2.1) | Import Drug Application | 2021-06-07 | | | | | view |
| CXSL1900049 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(15) | New Drug Application | 2019-05-27 | 杭州中美华东制药有限公司 | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | In Review | 2019-05-24 | view |
| JYSZ1600006 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | License Renew | 2016-04-18 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2017-01-25 | view |
